AZD2373-Arm 2 clinical trials

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

This study is testing a new drug, AZD2373, for a specific type of kidney disease called APOL1-Mediated Kidney Disease. It's looking at how well the drug works and if it's safe in people aged 18-65 with this condition.